Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZED1227 in Celiac Disease Subjects Experiencing Symptoms Despite Gluten-free Diet
NCT07298343Phase 2Recruiting
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Jun 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZED1227 in celiac disease, sponsored by Dr. Falk Pharma GmbH. Started Jun 2024; status: recruiting.
02
Drugs
ZED1227
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT07298343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07298343.